Drug details

RizaFilm (rizatriptan oral film)

type of Antimigraine Agents, Serotonin 5-HT-Receptor Agonists

RizaFilm (rizatriptan) is a serotonin (5-HT) 1B/1D receptor agonist (triptan) indicated for the acute treatment of migraine with or without aura in adults and in pediatric patients 12 to 17 years of age weighing 40 kg or more.

The drug is often used to treat Migraine .

This drug may have the following side effects:

• nausea,
• dizziness,
• drowsiness,
• dry mouth, and
• headache.
• weakness/fatigue,
• pain/pressure sensations in the head or body,

The following drugs are related to RizaFilm, either as a replacement or used together:

• Aimovig (erenumab-aooe injection, for subcutaneous use)
• Amerge (naratriptan)
• Migranal (dihydroergotamine mesylate spray)
• Relpax (eletriptan hydrobromide)
• Emgality (galcanezumab-gnlm injection)
• Vyepti (eptinezumab-jjmr injection for intravenous use)
• Ergomar (ergotamine tartrate tablets)
• Imitrex (sumatriptan succinate)
• Maxalt (rizatriptan benzoate)
• Sansert (methysergide maleate)
• Nurtec ODT (rimegepant orally disintegrating tablets, for sublingual or oral use)
• Treximet (sumatriptan and naproxen sodium tablets)
• Ubrelvy (ubrogepant tablets)